Mackenzie Financial’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,021
| Closed | -$244K | – | 1559 |
|
|
2025
Q4 | $244K | Buy |
+3,021
| New | +$203K | ﹤0.01% | 1461 |
|
|
2025
Q3 | – | Sell |
-3,165
| Closed | -$236K | – | 1760 |
|
|
2025
Q2 | $236K | Hold |
3,165
| – | – | ﹤0.01% | 1488 |
|
|
2025
Q1 | $201K | Hold |
3,165
| – | – | ﹤0.01% | 1522 |
|
|
2024
Q4 | $247K | Hold |
3,165
| – | – | ﹤0.01% | 1464 |
|
|
2024
Q3 | $254K | Hold |
3,165
| – | – | ﹤0.01% | 1264 |
|
|
2024
Q2 | $262K | Hold |
3,165
| – | – | ﹤0.01% | 1224 |
|
|
2024
Q1 | $270K | Hold |
3,165
| – | – | ﹤0.01% | 1218 |
|
|
2023
Q4 | $271K | Hold |
3,165
| – | – | ﹤0.01% | 1196 |
|
|
2023
Q3 | $276K | Hold |
3,165
| – | – | ﹤0.01% | 1166 |
|
|
2023
Q2 | $265K | Sell |
3,165
-9,032
| -74% | -$764K | ﹤0.01% | 1213 |
|
|
2023
Q1 | $1.01M | Buy |
12,197
+2,687
| +28% | +$218K | ﹤0.01% | 856 |
|
|
2022
Q4 | $748K | Buy |
9,510
+6,178
| +185% | +$497K | ﹤0.01% | 821 |
|
|
2022
Q3 | $247K | Sell |
3,332
-166
| -5% | -$11.9K | ﹤0.01% | 1162 |
|
|
2022
Q2 | $228K | Buy |
+3,498
| New | +$207K | ﹤0.01% | 1225 |
|
|
2021
Q4 | – | Sell |
-2,959
| Closed | -$209K | – | 1460 |
|
|
2021
Q3 | $209K | Buy |
+2,959
| New | +$187K | ﹤0.01% | 1307 |
|
|
2020
Q3 | – | Sell |
-5,922
| Closed | -$530K | – | 1013 |
|
|
2020
Q2 | $530K | Sell |
5,922
-340
| -5% | -$34.3K | ﹤0.01% | 783 |
|
|
2020
Q1 | $624K | Buy |
6,262
+762
| +14% | +$82.6K | ﹤0.01% | 768 |
|
|
2019
Q4 | $632K | Sell |
5,500
-18,293
| -77% | -$2.21M | ﹤0.01% | 819 |
|
|
2019
Q3 | $3M | Buy |
23,793
+443
| +2% | +$56.2K | 0.01% | 541 |
|
|
2019
Q2 | $2.81M | Sell |
23,350
-91,125
| -80% | -$8.97M | 0.01% | 561 |
|
|
2019
Q1 | $10M | Sell |
114,475
-81,750
| -42% | -$7.43M | 0.02% | 371 |
|
|
2018
Q4 | $19.6M | Buy |
196,225
+21,175
| +12% | +$2.22M | 0.05% | 251 |
|
|
2018
Q3 | $20.1M | Buy |
175,050
+51,620
| +42% | +$5.34M | 0.05% | 237 |
|
|
2018
Q2 | $11.1M | Buy |
+123,430
| New | +$10.4M | 0.03% | 303 |
|
|
2013
Q3 | – | Sell |
-51,400
| Closed | -$2.13M | – | 637 |
|
|
2013
Q2 | $2.13M | Buy |
+51,400
| New | +$2.08M | 0.01% | 382 |
|
Other funds holding HAE
RRAM
Mackenzie Financial's HAE Position: Q1 2026 in Review
Mackenzie Financial sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 3,021 shares — an estimated $244K sold.
Mackenzie Financial first reported a position in HAE in Q2 2013 and held it in 25 quarters. The position peaked at $20.1M in Q3 2018. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.
- Mackenzie Financial reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
- Mackenzie Financial sold 3,021 Haemonetics shares in Q1 2026, an estimated $244K.
- Mackenzie Financial first reported a position in Haemonetics in Q2 2013 and held it in 25 quarters.
- Mackenzie Financial's Haemonetics position peaked at $20.1M in Q3 2018.
- 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.
Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.